Pages that link to "Q73121472"
Jump to navigation
Jump to search
The following pages link to Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function (Q73121472):
Displaying 50 items.
- Axitinib for the Management of Metastatic Renal Cell Carcinoma (Q24613720) (← links)
- Chronic immune activation and inflammation as the cause of malignancy (Q24648532) (← links)
- Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy (Q24655930) (← links)
- Gene Therapy Applications to Cancer Treatment (Q24792808) (← links)
- Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy (Q24805285) (← links)
- Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy (Q26742107) (← links)
- Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data (Q26781098) (← links)
- Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity (Q26797280) (← links)
- Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapies (Q26830839) (← links)
- Immunotherapy advances for glioblastoma (Q26866513) (← links)
- Control of the immune response by pro-angiogenic factors (Q27004733) (← links)
- An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma (Q27024830) (← links)
- The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1 (Q28069924) (← links)
- Pharmacologic management of advanced cervical cancer: antiangiogenesis therapy and immunotherapeutic considerations (Q28086919) (← links)
- The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment (Q28241308) (← links)
- Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function (Q28392070) (← links)
- Tumor necrosis factor links chronic obstructive pulmonary disease and K-ras mutant lung cancer through induction of an immunosuppressive pro-tumor microenvironment (Q28392873) (← links)
- Influence of tumour micro-environment heterogeneity on therapeutic response (Q29617534) (← links)
- The immune contexture in human tumours: impact on clinical outcome (Q29620667) (← links)
- Immunosuppressive strategies that are mediated by tumor cells (Q29636247) (← links)
- Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia (Q30399006) (← links)
- Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy (Q30455612) (← links)
- Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice (Q30493889) (← links)
- AACR centennial series: the biology of cancer metastasis: historical perspective (Q33683443) (← links)
- Vaccines against human carcinomas: strategies to improve antitumor immune responses (Q33734281) (← links)
- The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells. (Q33924531) (← links)
- Potential applications of gene therapy in the patient with cancer (Q34030512) (← links)
- Secretion of immunoregulatory cytokines by mesenchymal stem cells. (Q34259098) (← links)
- CD47 signaling regulates the immunosuppressive activity of VEGF in T cells (Q34289358) (← links)
- VEGF as a mediator of tumor-associated immunodeficiency (Q34303192) (← links)
- Immunotherapy for prostate cancer (Q34328407) (← links)
- Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab (Q34417804) (← links)
- Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer (Q34450520) (← links)
- Combination cancer immunotherapy and new immunomodulatory targets (Q34487698) (← links)
- Immune surveillance of tumors (Q34579196) (← links)
- Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF. (Q35144428) (← links)
- Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy. (Q35627827) (← links)
- Umbilical cord blood-derived dendritic cells loaded with BGC823 tumor antigens and DC-derived exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumor immunity in vitro and in vivo (Q35686234) (← links)
- Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. (Q35748149) (← links)
- Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors (Q35793849) (← links)
- Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways. (Q35831115) (← links)
- Toll-like receptors as novel therapeutic targets for ovarian cancer (Q35864309) (← links)
- TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts (Q35894601) (← links)
- Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF. (Q35900957) (← links)
- Whole cell vaccines--past progress and future strategies (Q35975381) (← links)
- Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer (Q36057441) (← links)
- The role of dendritic cell precursors in tumour vasculogenesis. (Q36078034) (← links)
- Adhesion to substrates induces dendritic cell endothelization and decreases immunological response. (Q36146867) (← links)
- Immunotherapy of malignant brain tumors (Q36162929) (← links)
- Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. (Q36209876) (← links)